-
Je něco špatně v tomto záznamu ?
Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction
A. Di Martino, P. Kucharczyk, J. Zednik, V. Sedlarik,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- chitosan chemie MeSH
- koncentrace vodíkových iontů MeSH
- kyselina mléčná chemie MeSH
- léky s prodlouženým účinkem MeSH
- molekulová hmotnost MeSH
- nanočástice chemie MeSH
- polymery chemie MeSH
- rozpustnost MeSH
- sérový albumin hovězí chemie MeSH
- spektroskopie infračervená s Fourierovou transformací MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Chitosan and chitosan-grafted polylactic acid as a matrix for BSA encapsulation in a nanoparticle structure were prepared through a polyelectrolyte complexation method with dextran sulfate. Polylactic acid was synthetized via a polycondensation reaction using the non-metal-based initiator methanesulfonic acid and grafted to the chitosan backbone by a coupling reaction, with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as the condensing agent. The effect of concentration of the polymer matrix utilized herein on particle diameter, ζ-potential, encapsulation efficiency, and the release kinetic of the model protein bovine serum albumin at differing pH levels was investigated. The influence of pH and ionic strength on the behavior of the nanoparticles prepared was also researched. Results showed that grafting polylactic acid to chitosan chains reduced the initial burst effect in the kinetics of BSA release from the structure of the nanoparticles. Furthermore, a rise in encapsulation efficiency of the bovine serum albumin and diminishment in nanoparticle diameter were observed due to chitosan modification. The results suggest that both polymers actually show appreciable encapsulation efficiency; and release rate of BSA. CS-g-PLA is more suitable than unmodified CS as a carrier for controlled protein delivery.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000968
- 003
- CZ-PrNML
- 005
- 20170118112507.0
- 007
- ta
- 008
- 170103s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2015.10.017 $2 doi
- 024 7_
- $a 10.1016/j.ijpharm.2015.10.017 $2 doi
- 035 __
- $a (PubMed)26453778
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Di Martino, Antonio $u Centre of Polymer Systems, University Institute, Tomas Bata University in Zlin, Tr. T. Bati 5678, 760 01 Zlin, Czech Republic.
- 245 10
- $a Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction / $c A. Di Martino, P. Kucharczyk, J. Zednik, V. Sedlarik,
- 520 9_
- $a Chitosan and chitosan-grafted polylactic acid as a matrix for BSA encapsulation in a nanoparticle structure were prepared through a polyelectrolyte complexation method with dextran sulfate. Polylactic acid was synthetized via a polycondensation reaction using the non-metal-based initiator methanesulfonic acid and grafted to the chitosan backbone by a coupling reaction, with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as the condensing agent. The effect of concentration of the polymer matrix utilized herein on particle diameter, ζ-potential, encapsulation efficiency, and the release kinetic of the model protein bovine serum albumin at differing pH levels was investigated. The influence of pH and ionic strength on the behavior of the nanoparticles prepared was also researched. Results showed that grafting polylactic acid to chitosan chains reduced the initial burst effect in the kinetics of BSA release from the structure of the nanoparticles. Furthermore, a rise in encapsulation efficiency of the bovine serum albumin and diminishment in nanoparticle diameter were observed due to chitosan modification. The results suggest that both polymers actually show appreciable encapsulation efficiency; and release rate of BSA. CS-g-PLA is more suitable than unmodified CS as a carrier for controlled protein delivery.
- 650 _2
- $a chitosan $x chemie $7 D048271
- 650 _2
- $a léky s prodlouženým účinkem $7 D003692
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a kyselina mléčná $x chemie $7 D019344
- 650 _2
- $a molekulová hmotnost $7 D008970
- 650 _2
- $a nanočástice $x chemie $7 D053758
- 650 _2
- $a polymery $x chemie $7 D011108
- 650 _2
- $a sérový albumin hovězí $x chemie $7 D012710
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a spektroskopie infračervená s Fourierovou transformací $7 D017550
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kucharczyk, Pavel $u Centre of Polymer Systems, University Institute, Tomas Bata University in Zlin, Tr. T. Bati 5678, 760 01 Zlin, Czech Republic.
- 700 1_
- $a Zednik, Jiri $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University in Prague, Hlavova 2030/8, Prague 2 128 43, Czech Republic.
- 700 1_
- $a Sedlarik, Vladimir $u Centre of Polymer Systems, University Institute, Tomas Bata University in Zlin, Tr. T. Bati 5678, 760 01 Zlin, Czech Republic. Electronic address: sedlarik@ft.utb.cz.
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 496, č. 2 (2015), s. 912-21
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26453778 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170118112613 $b ABA008
- 999 __
- $a ok $b bmc $g 1180108 $s 961535
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 496 $c 2 $d 912-21 $e 20151024 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20170103
